Proton Beam Radiation Therapy

REFERENCES

• Goitein M., Jermann M. The relative costs of proton and x-ray radiation therapy. Clin. Oncol. (R. Coll. Radiol.) 2003; 15(1)S37–S50, [CSA]
   PubMed Web of Science ®Google Scholar
• Lundkvist J., Ekman M., Ericsson S. R., et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005; 103: 793–801, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Davis R. J. Proton-beam therapy for cancer. Wall Street Journal. February, 12005
   Google Scholar
• Bussiere M. R., Adams J. A. Treatment planning for conformal radiation therapy. Tech. Cancer Res. Treat. 2003; 2(5)389–399, [CSA]
   PubMed Web of Science ®Google Scholar
• Hall E. J. Radiobiology for the radiologist, 5th ed. Lippincott Williams & Wilkins, Philadelphia 2000; 546
   Google Scholar
• Tepper J., Verhey L., Goieten M., et al. In vivo determinations of RBE in a high energy modulated proton beam using normal tissue reactions and fractionated dose schedules. Int. J. Radiat. Oncol. Biol. Phys. 1977; 2: 1115–1122, [CSA]
   PubMed Web of Science ®Google Scholar
• Urano M., Verhey L. J., Goitein M., et al. Relative biological effectiveness of modulated proton beams in various murine tissues. Int. J. Radiat. Oncol. Biol. Phys. 1984; 10: 509–514, [CSA]
   PubMed Web of Science ®Google Scholar
• Gerweck L. E., Kozin S. V. Relative biological effectiveness of proton beams in clinical therapy. Radiother. Oncol. 1999; 50: 135–142, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pagnetti H., Niemierko A., Ancukiewitz M., et al. Relative biological effectiveness (RBE) values for proton beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 407–421, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Khan F. M. The physics of radiation therapy, 3rd ed. Lippincott Williams & Wilkins, Philadelphia 2003; 481
   Google Scholar
• Weber D. C., Trofimov A. V., DeLaney T. F., Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 2004; 58: 1596–1606, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Miralbell R., Lomax A., Cell C., et al. Potential reduction of the incidence of radiation induced second cancers by using proton beams in the treatment of pediatric tumors. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54(3)824–829, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gragoudas E. S., Li W., Goitein M., et al. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Opthalmol. 2002; 120(12)1665–1671, [CSA]
   PubMed Web of Science ®Google Scholar
• Egan K. M., Gragoudis E. S., Seddon J. M., et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989; 96(9)1377–1382, [CSA]
   PubMed Web of Science ®Google Scholar
• Gragoudas E. S., Lane A. M., Regan S., et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch. Ophthalmol. 2000; 118(6)773–778, [CSA]
   PubMed Web of Science ®Google Scholar
• Courdi A., Caujolle J. P., Grange J. D., et al. Results of proton therapy of uveal melanomas treated in Nice. Int. J. Radiat. Oncol. Biol. Phys. 1999; 45(1)5–11, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Egger E., Schalenbourg A., Zografos L., et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51(1)138–147, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Egger E., Zografos L., Schalenbourg A., et al. Eye retention after proton beam radiotherapy for uveal melanoma. [Review] [20 refs]. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55(4)867–880, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaste S. C., Chen G., Fontanesi J., et al. Orbital development in long-term survivors of retinoblastoma. J. Clin. Oncol. 1997; 15: 1183–1189, [CSA]
   PubMed Web of Science ®Google Scholar
• Imhof S. M., Mourtis M. P., Hofman P., et al. Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology 1996; 103: 263–268, [CSA]
   PubMed Web of Science ®Google Scholar
• Croughs P., Denman C., Richard F., et al. Treatment of retinoblastoma using accelerated protons. Bull Soc. Beige Opthalmol. 1992; 243: 81–85, [CSA]
   PubMedGoogle Scholar
• Krengli M., Hug E. B., Adams J. A., et al. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int. J. Radiat. Oncol. Biol. Phys. 2005; 61: 583–593, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Munzenrider J. E., Liebsch N. J. Proton therapy for tumors of the skull base. Strahlenther Onkiol 1999; 175(Suppl 2)57–63, [CSA]
   PubMed Web of Science ®Google Scholar
• Rosenberg A. E., Nielson G. P., Keel S. B., et al. Chondrosarcoma of the base of skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am. J. Surg. Pathol. 1999; 23(11)1370–1378, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hug E. B., Loredo L. N., Slater J. D., et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J. Neurosurgery 1999; 91: 432–439, [CSA]
   PubMed Web of Science ®Google Scholar
• Noel G., Habrand J. L., Mammar H., et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D'Orsay experience. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51(2)392–398, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hug E. B., Fitzek M. M., Liebsch N. J., Munzenrider J. E. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined photon and proton radiation therapy using three-dimensional treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 467–476, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McAllister B., Archambeua J. O., Nguyen M. C., et al. Proton therapy for pediatric cranial tumors: preliminary report on treatment and disease-related morbidities. Int. J. Radiat. Oncol. Biol. Phys. 1997; 39(2)455–460, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fuss M., Hug E. B., Schaefer R. A., et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int. J. Radiat. Oncol. Biol. Phys. 1999; 45(5)1117–1126, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kun L. E. Tumors of the posterior fossa and spinal canal: Pediatric radiation oncology, 4th ed. Lippincott Williams & Wilkins, Philadelphia 2005; 89–133
   Google Scholar
• St. Clair W. H., Adams J. A., Bues M., et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 2004; 58(3)727–734, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lin R., Hug E. B., Schaefer R. A., et al. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48(4)1219–1226, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fitzek M. M., Thornton A. F., Rabinov J. D., et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J. Neurosurg 1999; 91(2)251–260, [CSA]
   PubMed Web of Science ®Google Scholar
• Wenkel E., Thornton A. F., Finkelstein D., et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48(5)1363–1370, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hug E. B., DeVries A., Thornton A. F., et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol. 2000; 48: 151–160, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bush D. A., McAllister C. J., Loredo L. N., et al. Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery 2002; 50(2)270–273, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weber D. C., Chan A. W., Bussiere M. R., et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery 2003; 53(3)577–588, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Harsh G., Loeffler J. S., Thornton A., et al. Stereotactic proton radiosurgery. Neurosurg Clin. N. Am. 1999; 10(2)243–256, [CSA]
   PubMed Web of Science ®Google Scholar
• Fitzek M. M., Thornton A. F., Varvares M., et al. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 2002; 94(10)2623–2634, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lin R., Slater J. D., Yonemoto L. T., et al. Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy—dose-volume histogram analysis. Radiology 1999; 213(2)489–494, [CSA]
   PubMed Web of Science ®Google Scholar
• Shipley W. U., Verhey L. J., Muzenrider J. E., et al. Advanced prostate cancer: results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using protons alone. Int. J. Radiat. Oncol. Biol. Phys. 1995, 32: 3–12, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Slater J. D., Rossi C. J., Jr., Yonemoto L. T., et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int. J. Radiat. Oncol. Biol. Phys. 2004; 59(2)348–352, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zietman A. L., DeSilvio M., Slater J. D., et al. A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate: results of an interim analysis of PROG 95-09. Int. J. Radiat. Oncol. Biol. Phys. 2004; 60(Number 1)S131, Supplement[CSA], [CROSSREF]
   Google Scholar
• Cella L., Lomax A., Mirabell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 217–223, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lomax J. A., Cella L., Weber D., et al. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55(3)785–792, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Poon R. T., Fan S. T., Tsang F. H., et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann. Surg. 2002; 235: 466–486, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Matsuzaki Y., Osuga T., Chiba T., et al. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Intern. Med. 1995; 34: 302–307, [CSA]
   PubMed Web of Science ®Google Scholar
• Bush D. A., Hillebrand D. J., Slater J. M., et al. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 2004; 127(5)sl89–sl93, [CSA]
   Google Scholar
• Koyama S., Tsuji H. Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. Clinical Cancer Research 2003, 9: 3571–3577, [CSA]
   PubMedGoogle Scholar
• Hsiung-Stripp D. C., McDonough J., Masters H. M., et al. Comparative treatment planning between proton and X-ray therapy in pancreatic cancer. Med. Dosim. 2001; 26(3)255–259, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Isacsson U., Montelius A., Jung B., et al. Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother. Oncol. 1996; 41(3)263–272, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bush D. A., Slater J. D., Bonnet R., et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999; 116(5)1313–1319, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lundkvist J., Ekman M., Ericsson S R., et al. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiotherapy and Oncology 2005; 75: 179–185, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar